• Recent Posts

  • About Clinical Trials: What They Can Mean For You?
  • PRI's Patient Resource Center
  • Patient Recruiters International, Inc. Launches Clinicalstudy.org
  • The Use of Intent Scale Translations to Predict Purchase Interest
  • PRI Launches GoHealthPanel.com for Connecting People with Research
  • BioTrak Research Inc. Spins Out Patient Recruiters International, Inc.
  • 3rd Annual Bio/Pharmaceutical Drug Safety Forum
  • Mitigate Medical Product Risk and Improve Safe Use
  • BioTrak announces the launch of a new dedicated REMS information site

• REMS Zone

  • FDA approves Exjade to remove excess iron in patients with genetic blood disorder
  • FDA approves Botox to treat overactive bladder
  • FDA approves Octaplas to treat patients with blood clotting disorders
  • FDA permits marketing of first test that can simultaneously identify 11 causes of infectious gastroenteritis
  • FDA requiring lower recommended dose for certain sleep drugs containing zolpidem

BioTrak Research Tel:760.448.4820
Fax: 760.603.9535
contactus@biotrak.com